Sami Shaker Qutob, Ph. D., Health Canada
Abstract
There is considerable controversy surrounding the biological effects of
radiofrequency (RF) fields, as emitted by mobile phones. Previous work from
our laboratory has shown no effect related to the exposure of 1.9 GHz
pulse-modulated RF fields on the expression of 22,000 genes in a human
glioblastoma derived cell-line (U87MG) at 6 h following a 4 h RF field
exposure period. As a follow-up to this study, we have now examined the
effect of RF field exposure on the possible expression of late onset genes
in U87MG cells after a 24 h RF exposure period. In addition, a human
monocyte-derived cell-line (Mono-Mac-6, MM6) was exposed to intermittent (5
min ON, 10 min OFF) RF fields for 6 h and then gene expression was assessed
immediately after exposure and at 18 h post-exposure. Both cell lines were
exposed to 1.9 GHz pulse-modulated RF fields for 6 or 24 h at specific
absorption rates (SARs) of 0.1 - 10.0 W/kg. In support of our previous
results, we found no evidence that non-thermal RF field exposure could
alter gene expression in either cultured U87MG or MM6 cells, relative to
non-irradiated control groups. However, exposure of both cell-lines to
heat-shock conditions (43oC for 1 h) caused an alteration in the expression
of a number of well characterized heat shock proteins.
References
Vinita Chauhan1, Sami S. Qutob1, Stephanie Lui1, Anu Mariampillai1, Pascale
V. Bellier1, Carole L. Yauk2, George R. Douglas2, Andrew Williams3, and
James P. McNamee*1
- Consumer and Clinical Radiation Protection Bureau, Healthy Environment and
Consumer Safety Branch, Health Canada, Ottawa, Ontario, Canada, K1A 1C1.
- Mutagenesis Section, Environmental Health Science Bureau, Healthy
Environment and Consumer Safety Branch, Health Canada, Ottawa, Ontario,
Canada, K1A 0L2.
- Biostatistics and Epidemiology Division, Healthy Environment and Consumer
Safety Branch, Health Canada, Ottawa, Ontario, Canada, K1A 0L2.
Biography
In 1995, Dr. Qutob completed an Honors thesis in physiology at the
University of Western Ontario based on the characterization of sacroplasmic
reticulum proteins in the AT-1 mouse atrial tumor cell line. Following
this, he sought a M.Sc. degree in physiology at the same institution
studying the effects of insulin on vitamin C uptake by osteoblastic and
astroglial cells employing many biochemical and cell culture techniques.
Since that time he has been actively involved in a range of projects,
especially in the field of non-ionizing and ionizing radiation biology
research. During his doctoral studies, at the Ottawa Regional Cancer
Center, he examined the genetic factors that govern cellular
radioresponsiveness as well as addressing the ability of exogenous factors
(i.e. chemo-drugs) to modulate ionizing radiation sensitivity.
Collaboration with Dr Qing Yan Liu and Dr. P. Roy Walker at the
Neurogenomics Group, Institute for Biological Sciences, National Research
Council of Canada (NRC) has enabled Dr. Qutob to gain valuable experience
in the area of genomics research particularly in the area of cDNA
microarray technology. Following completion of his Ph. D. studies, this
expertise was further utilized where he spent a year at Health Canada
performing Postdoctural fellowship research. During this time, the
candidate examined the effects of non-ionizing 1.9 GHz pulse-modulated
radiofrequency fields on microarray gene expression of a human glioblastoma
cell line. Since April 1st, 2004, Dr. Qutob has led a Health Canada
partnership with the Radiological Analysis and Defence Group at Defence
Research and Development Canada (DRDC Ottawa) in a project funded by the
Chemical, Biological, Radiological and Nuclear (CRBN) Research and
Technology Initiative (CRTI). This collaboration involved several federal
and industry partners for the purpose of identifying possible biomarkers of
ionizing radiation exposure and developing a National Biological Dosimetry
Response Plan (NBDRP) in response to a large-scale radiological event. Data
obtained from a number of CRTI sub-projects has shown promise and may
possibly lead to the development of a prototype fieldable biodosimeter for
rapid triage of potentially exposed individuals. As of January, 2007, the
candidate has returned to Health Canada as a principle investigator (P.I.),
examining the mechanisms of hormesis, radioadaptation, and combined
biological effects of radiation in order to provide new information on
radiation safety, consistent with Health Canada's mandate. He is a
member of the Bioelectromagnetics Society and Radiation Research Society.